期刊文献+

老年急性心力衰竭患者血清miR-181b表达与心功能指标及预后的关系 被引量:6

The expression of miR-181b in elderly patients with acute heart failure and its relationship with cardiac function indexes and prognosis of patients
暂未订购
导出
摘要 目的探讨老年急性心力衰竭患者血清miR-181b表达与心功能指标及预后的关系。方法选择2015年11月至2017年11月收治的86例老年急性心力衰竭患者作为观察组,并根据纽约心脏学会(NYHA)分级的不同分为Ⅱ级组26例、Ⅲ级组32例、Ⅳ级组28例。选择同期健康体检人群40例为对照组。采用qRT-PCR检测研究对象血清miR-181b水平表达量。比较不同组血清miR-181b水平以及心功能指标关系的关系,并采用Logistic回归分析探讨血清miR-181b表达水平与老年急性心力衰竭患者随访1年的预后关系。结果血清BNP、LVEF比较差异有统计学意义(P<0.05);4组血清miR-181b水平比较差异均有统计学意义(P<0.05),心功能Ⅳ级组的血清miR-181b水平表达明显低于心功能Ⅱ级组、心功能Ⅲ级组、对照组(心功能Ⅳ级组<心功能Ⅲ级组<心功能Ⅱ级组<对照组,P<0.01);血清miR-181b水平与血清脑钠肽(BNP)呈负相关(r=-0.654,P=0.001);血清miR-181b水平与血清LVEF呈正相关(r=0.467,P=0.001);所有患者经过1年随访,其中24例患者发生不良结果,其血清miR-181b水平明显低于非不良事件患者(P<0.05);Logistic回归分析表示,血清BNP≥200 pg/L(OR=3.50,95%CI:2.63~4.67)、LVEF≤50%(OR=3.08,95%CI:1.92~4.94)、miR-181b≤19.28(OR=4.26,95%CI:1.92~5.46)为急性心力衰竭患者预后良好的危险因素。结论血清miR-181b水平在急性心力衰竭患者中的表达水平降低,且在预后不良患者中表达水平降至更低,因此血清miR-181b水平与急性心力衰竭患者的预后有重要关系。 Objective To investigate the correlation between the expression of miR-181b and cardiac function indexes as well as prognosis of elderly patients with acute heart failure.Methods A total of 86 elderly patients with acute heart failure who were admitted and treated in our hospital from November 2015 to November 2017 were enrolled as observation group,and 40 healthy subjects who underwent physical examination in our hospital were enrolled as control group.The observation group was redivided into three subgroups according to the New York Heart Association(NYHA)classification,namely,gradeⅡgroup(n=26),gradeⅢgroup(n=32)and gradeⅣgroup(n=28).The expression levels of serum miR-181b were measured by qRT-PCR,and its correlation with the cardiac function index and prognosis after 1-year follow up was analyzed.Results There were significant differences in the serum levels of BNP and LVEF among the four groups(P<0.05).there were significant differences in the serum levels of miR-181b among the four groups(P<0.05).The serum levels of miR-181b were in order(from high to low)gradeⅣgroup,gradeⅢgroup,gradeⅡgroup and control group(P<0.01).Moreover the serum levels of miR-181b were negatively correlated with those of BNP(P<0.01),which were positively correlated with those of LVEF(P<0.01).In addition 24 patients had adverse reactions after 1-year follow up,and the serum levels of miR-181b in patient with adverse reactions were significantly lower than those of patients without adverse reactions(P<0.05).Logistic regression analysis showed that serum BNP≥200pg/L,LVEF≤50%,miR-181b≤19.28 were the risk factors for patients with acute heart failure.Conclusion The serum levels of miR-181b are decreased in patients with acute heart failure,and its expression levels are even lower in patients with poor prognosis,therefor,the serum miR-181b levels are losely correlated with the prognosis of patients with acute heart failure.
作者 黄如彬 王利莎 丁力 HUANG Rubin;WANG Lisha;DING Li(Department of Geriatric General Medicine,Jiangjin District Central Hospital of Chongqing City,Chongqing 402260,China)
出处 《河北医药》 CAS 2019年第22期3448-3450,3454,共4页 Hebei Medical Journal
基金 重庆市卫生计生委科研基金项目(编号:2016MSXM149)
关键词 miR-181b 急性心力衰竭 心功能指标 预后 miR-181b acute heart failure cardiac function indexes prognosis
  • 相关文献

参考文献16

二级参考文献179

  • 1李世强,傅向华,刘君,谷新顺,张晶,樊欣娜,姜云发,苗青.静脉注射重组人脑利钠肽对急性心肌梗死伴心力衰竭患者的急性血流动力学效应的研究[J].中华心血管病杂志,2006,34(1):23-27. 被引量:102
  • 2谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 3刘莉,邹国良,索传涛.利心I号对CHF大鼠血流动力学、心肌细胞ICAM-1基因蛋白表达的影响[J].心脏杂志,2007,19(2):166-169. 被引量:1
  • 4中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 5中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 6Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 7Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 8Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 9Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 10Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.

共引文献5846

同被引文献80

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部